Time
Days to earnings13
Next print2026-10-29
WindowBMO
Fiscal2026-09-30
NYSE · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
LLY
Eli Lilly and Company primary
1,182.06
Full stocks workspace →+3.35+0.3%
Street
Consensus EPS9.956
Consensus revenue22.4B
EPS high / low11.305 / 9.23 · 20.8% · n=17
Rev / avg1 / — · 9.932 / 9.871
Options
IV front29.8%
Implied move6.4%
Put/call full1.14
Put/call front1.23
Short interest
Short shares7.0M / 7.5M · -6.44%
Days to cover2.93
Avg vol · float2.4M · 848.7M
Short % float0.83%
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 13 | 2026-10-29 | 1,182.06 | 9.956 | 29.8% | 6.4% | +3.4% | -0.2% | +3.8% | +0.6% | 11.305 / 9.23 | 20.8% | 17 | 1.14 | 0 | |
| 2026-10-09 | 14 | 2026-10-29 | 1,178.71 | 9.956 | 31.7% | 7.4% | +3.1% | -0.4% | +5.6% | +0.2% | 11.305 / 9.23 | 20.8% | 17 | 1.13 | 0 | |
| 2026-10-08 | 15 | 2026-10-29 | 1,169.93 | 9.956 | 31.7% | 7.6% | +1.7% | -1.0% | +4.2% | -1.6% | 11.305 / 9.23 | 20.8% | 17 | 1.16 | 0 | |
| 2026-10-07 | 16 | 2026-10-29 | 1,188.46 | 9.956 | 29.8% | 7.3% | +2.7% | +3.3% | +5.7% | -3.7% | 11.305 / 9.23 | 20.8% | 17 | 1.17 | 0 | |
| 2026-10-06 | 17 | 2026-10-29 | 1,158.00 | 9.956 | 33.2% | 8.3% | -2.2% | -1.0% | +3.0% | -7.1% | 11.305 / 9.23 | 20.8% | 17 | 1.18 | 0 | |
| 2026-10-05 | 18 | 2026-10-29 | 1,144.98 | 9.932 | 31.2% | 8.0% | -3.4% | -1.7% | -0.4% | -8.8% | 11.305 / 9.23 | 20.9% | 17 | 1.14 | 0 | |
| 2026-10-02 | 19 | 2026-10-29 | 1,144.20 | 9.932 | 31.7% | 8.6% | -3.3% | -0.8% | -1.3% | -8.1% | 11.305 / 9.23 | 20.9% | 17 | 1.15 | 0 | |
| 2026-10-01 | 20 | 2026-10-29 | 1,150.06 | 9.932 | 34.7% | 9.6% | -2.7% | -0.2% | -0.9% | -10.2% | 11.305 / 9.23 | 20.9% | 17 | 1.17 | 0 | |
| 2026-09-30 | 21 | 2026-10-29 | 1,160.11 | 9.932 | 33.2% | 9.4% | +0.8% | +2.0% | +0.0% | -5.4% | 11.305 / 9.23 | 20.9% | 17 | 1.17 | 0 | |
| 2026-09-29 | 22 | 2026-10-29 | 1,185.68 | 9.932 | 33.2% | 9.5% | +1.3% | +4.4% | +2.5% | +0.2% | 11.305 / 9.23 | 20.9% | 17 | 1.19 | 0 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| MRK primary | Merck & Company Inc | 0.44 | 2026Q2 · 2026-08-04 | +50.0% | +0.5% | 128.00 | 13 · 2026-10-12 |
| PFE primary | Pfizer Inc | 0.44 | 2026Q2 · 2026-08-04 | +13.2% | +0.0% | 25.41 | 16 · 2026-10-12 |
| JNJ primary | Johnson & Johnson | 0.42 | 2026Q2 · 2026-07-15 | +2.1% | -1.5% | 247.02 | 1 · 2026-10-12 |
| ABBV primary | AbbVie Inc | 0.38 | 2026Q2 · 2026-07-31 | +0.3% | -1.9% | 250.94 | 14 · 2026-10-12 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-08-05 | BMO | 8.38 | +39.4% | Beat | +5.2% | -0.4% | 2.63× | +9.4% | Review |
| 2026Q1 | 2026-04-30 | BMO | 8.55 | +25.9% | Beat | +5.6% | +4.0% | 2.70× | +7.7% | Review |
| 2025Q4 | 2026-02-04 | BMO | 7.54 | +5.2% | Beat | +7.1% | +3.0% | 2.32× | -7.6% | Review |
| 2025Q3 | 2025-10-30 | BMO | 7.02 | +19.2% | Beat | +2.9% | +0.8% | 2.27× | +21.1% | Review |
| 2025Q2 | 2025-08-07 | BMO | 6.31 | +12.5% | Beat | -9.5% | -5.2% | 6.19× | +10.8% | Review |
| 2025Q1 | 2025-05-01 | BMO | 3.34 | -3.5% | Miss | -6.1% | -5.9% | 3.16× | -7.7% | Review |
| 2024Q4 | 2025-02-06 | BMO | 5.32 | +5.0% | Beat | -0.3% | +3.7% | 2.18× | +0.4% | Review |
| 2024Q3 | 2024-10-30 | BMO | 1.18 | -19.7% | Miss | -11.6% | +6.1% | 8.67× | -4.1% | Review |
| 2024Q2 | 2024-08-08 | BMO | 3.92 | +41.5% | Beat | +13.3% | -3.4% | 2.42× | +12.9% | Review |
| 2024Q1 | 2024-04-30 | BMO | 2.58 | +3.6% | Beat | +5.1% | +0.8% | 3.01× | -2.2% | Review |